MXCT - MaxCyte to join Russell 2000 and 3000 Index

MaxCyte (NASDAQ:MXCT) to join the Russell 3000 and Russell 2000 indices, effective after the U.S. market opens on September 20, 2021. "The addition of MaxCyte to the Russell indices highlights our strong financial profile and marks a milestone in our progress towards being the premier cell engineering platform technology.” said Doug Doerfler, President and CEO. Recent Bullish rating on the stock by contributor who comments: 'MaxCyte: Enabling Next-Generation Cell Based Therapies, Attractive Risk-Return Profile'

For further details see:

MaxCyte to join Russell 2000 and 3000 Index